Mineralocorticoid Blocker Gets EU Nod for Heart Failure

Kerendia may soon be authorized in the EU for heart failure and an ejection fraction of 40% or higher.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/mineralocorticoid-blocker-gets-eu-nod-heart-failure-2026a10003cs?src=rss

Author :

Publish date : 2026-02-03 12:38:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Mineralocorticoid Blocker Gets EU Nod for Heart Failure

Pneumonia Admissions Climb as Charity Flags Care Gaps

CGRPs for Migraine Tied to ‘Modest’ Heart Risk

Related Posts

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

‘I’m not being listened to’ – new health plan launched as women say they are still ignored

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

Surgeon Accused of Removing Wrong Organ Faces Manslaughter Charge

FDA Approves Sparsentan as First FSGS Treatment

A Simple Test Could Predict a Patient’s Final 24 Hours

Multidose Ibuprofen Regimen Eases IUD Insertion Pain

‘I’m not being listened to’ – new health plan launched as women say they are still ignored

Brokers Get Paid More to Enroll Seniors in Medicare Advantage. Is That a Problem?

Surgeon Accused of Removing Wrong Organ Faces Manslaughter Charge

FDA Approves Sparsentan as First FSGS Treatment

A Simple Test Could Predict a Patient’s Final 24 Hours

Undetected TB May Be Lurking in U.S. Hospitals, Ultrasensitive Assay Suggests

Is a super El Niño imminent, and what could the impacts be?

Categories

Archives